Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Bullboard Posts
Post by dustyboyon May 30, 2018 4:48pm
163 Views
Post# 28101542

Rereading recent nr's

Rereading recent nr'sApril 27 - the April 19th-announced financing is finished in 8 days (first tranche).

May 8 - new testing to be done with Thermal Therapy + CBD/THC
- previous (Feb 1) agreement with Quinsam to develop a pain relieving thermal therapy device cancelled, and instead Quinsam is supporting TB with a CD financing $250k.
- Dr. Bennett new board member.  20 years pain, nerves and cancer, last 5 years shifted to cannibis research.
- Bruno Maruzzo new board member.  Business type guy.
- Purchase agreement with no-no cancelled
- options given to O&D vested for 6 months

May 10 - financing with second tranche extended but no later than June 9
- Acquisition of the domain coldsores.com
- InterceptCS to be rebranded and social media advertising

I'm guessing the CBD/THC testing and development will use some of the raised funds.

Bullboard Posts